Prediction of short-term survival by four scoring systems based on MELD in patients with acute-on-chronic hepatitis B-induced liver failure

李磊,胡辉,郑晓玮,江守伟,沈强

DOI: https://doi.org/10.3969/j.issn.1672-5069.2018.03.025

2018-01-01

Abstract:Objective To validate the prediction of short-term survival by four scoring systems based on models for end-stage liver disease(MELD)in patients with acute-on-chronic hepatitis B-induced liver failure (HBV-ACLF). Methods 67 patients with HBV-ACLF were enrolled in this study between April 2015 and October 2017. The clinical parameters were collected for calculation of MELD,iMELD,MELD-Na and MESO scores,respectively. The predictive efficacy on forecasting survival of patients with HBV-ACLF by the four scoring systems was analyzed by receiver operating characteristic curve(ROC)supported by MedCalc15.8 software. Results 45(67.2%)out of 67 patients with HBV-ACLF died within 12 weeks;the scores of MELD,iMELD, MELD-Na and MESO models at presentation in survival group were(22.12±3.24),(41.59±5.30),(22.55±4.07) and(1.64±0.24),much lower than[(30.47±9.01),(51.88±11.09),(32.35±11.58)and(2.28±0.70),respectively,P<0.01]in the dead group;the area under the ROC curve(AUC)in forecasting the survival of patients with HBV-ACLF by the four models were 0.814,0.802,0.806 and 0.817 respectively,the cut -off -values were 22.70,47.76,22.16 and 1.69,and the Jordan index were 0.5040,0.5535,0.4808 and 0.4818,respectively,suggesting no significant differences between them(P>0.05). Conclusion The four scoring systems base on MELD have good predictive efficacy on forecasting 12 weeks'survival in patients with HBV-ACLF,which hints they might be applied in clinical practice.